Medicare

In Spite of Trump’s Marijuana Executive Order, FDA Hemp and Marijuana Botanical Guidance Will Prevail

FDA Law-Not Hemp, Marijuana Politics-Will Decide the Future of Cannabinoid Medicine.Why "Full-Spectrum CBD" Narratives Are Collapsing-and Why MMJ International Holdings…

2 weeks ago

Adia Nutrition Inc. Recaps Transformative 2025: Explosive Growth, Strategic Focus, and Path to Nasdaq Uplisting

Winter Park, Florida--(Newsfile Corp. - December 29, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem…

2 weeks ago

Best Semaglutide Options for 2026: New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways

Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists Compounded Options Alongside New FDA-Approved…

2 weeks ago

CareOregon – Notice of Data Event

PORTLAND, Ore., Dec. 26, 2025 /PRNewswire/ -- On or about October 27, 2025, CareOregon learned that one or more people looked…

2 weeks ago

Jackson Care Connect – Notice of Data Event

PORTLAND, Ore., Dec. 26, 2025 /PRNewswire/ -- On or about October 27, 2025, Jackson Care Connect learned that one or…

2 weeks ago

Columbia Pacific CCO – Notice of Data Event

PORTLAND, Ore., Dec. 26, 2025 /PRNewswire/ -- On or about October 27, 2025, Columbia Pacific CCO learned that one or more people…

2 weeks ago

Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations

While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn LCDs, Celularity CEO Dr. Robert…

3 weeks ago

2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement

Black Book Research Q4 flash survey shows health plans shifting from effort-based sourcing to KPI-backed operating models, tightening third- and…

3 weeks ago

Best Peptides for Muscle Growth: Prescription Sermorelin Access, Injectable vs. Dissolving Tablets, and Realistic Expectations

Platform Analysis: Injectable vs. Dissolving Tablet Formats, Prescription Requirements, Monthly Subscription Costs, and Timeline Expectations for Growth Hormone Secretagogue TherapyAUSTIN,…

3 weeks ago

Organogenesis Announces Initiation of Biologics License Application for ReNu®

Initial modules submitted to FDA under rolling review; final modules expected in the first half of 2026CANTON, Mass., Dec. 23,…

3 weeks ago